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820-3 Accuracy and Reliability of Intracardiac 
Echocardiography Guided Device Closure of Atrial 
Septal Defects 
Michael J. Mullen. Brian F. Diaz, Fiona Walker, Samuel C. Sui, Lee Benson, Peter R. 
McLaughlin, Toronto General Hospital, Toronto, Ontario, Canada, Hospital for Sick 
Children, Toronto, Ontario, Canada. 
Background: The recent development of intracardiac echocardiography (ICE) has added 
a further dimension to the imaging modafities available to cardiologists. We therefore 
prospectively assessed the feasibility and accuracy of ICE in assessing device closure of 
secundum atdal septal defects (ASD). 
Methods: ICE was used as the primary echocardiographic modality for guiding device 
closure of secundum ASD in consecutive patients. The primary endpoint was the satis- 
factory position of the occluding device, after deployment but prior to its release from the 
delivery system. For each device septal capture was assessed in longitudinal and short 
axis views and judged to be satisfactory or unsatisfactory using a dichotomous variable. 
Sequential transesophageal echocardiographic (TEE) examinations were performed, 
independently, to confirm the accuracy and reliability of ICE immediately after completion 
of the ICE examination. Potentially adverse procedural events (PAPEs) that might impact 
on the success of the interventional procedure were logged. 
Results: High quality ICE images were achieved in all the patients, though views were 
limited in 2 patients with grossly aneurysmal atdal septa. ICE was used to guide the clo- 
sure of 36 ASD in 34 patients, with confirmatory TEE data available for 25 devices in 23 
patients. The median ASD size was 15.4 ± 4.6 mm (range 4 to 25 mm) with a stretched 
diameter of 19.2 ± 5.7 (range 6 to 32). There was close agreement between ICE and 
TEE in assessing satisfactory septal capture (99%). A total of 9 PAPEs, including device 
malpositions, additional defects and anomalous pulmonary venous drainage, which 
required remedial action, were detected by ICE in 7 patients. No additional PAPEs were 
detected by TEE, however, ICE detected 2 defects not initially seen by TEE. There were 
no complications associated with the use of ICE. 
Conclusion: We have demonstrated the accuracy and reliability of ICE in guiding device 
closure of ASD comparable to that of TEE. ICE detected all PAPEs, which would impact 
on the successful outcome of the procedure and will facilitate the closure of ASD without 
the need for general anesthesia. 
11:45 a.m. 
820-5 Percutaneous Closure of Patent Foremen Ovale in 
Patients With Paradoxical Embolism: Impact of Patent 
Foremen Ovale Dedicated Devices on Procedural 
Complications and Residual Shunt 
Markus Schwerzmann. Bernhard Meier, Andreas Wahl, Franz R. Ebedi, Christian Seller, 
Haresh Mehte, Marianne Zimmerli, Stephan Windecker, Swiss Cardiovascular Center 
Bern, Cardiology, Bern, Switzerland. 
Background: Percutaneous treatment of atrial septal abnormalities is feasible using a 
vahety of devices. Structural and functional differences between patent foremen ovale 
(PFO) and atrial septal defects have led to the development of PFO dedicated devices. 
The purpose of the present study was to compare the safety and efficacy between the 
PFO Star device (PFO-S) and Amplatzer PFO occluder (PFO-A). 
Methods: Implantation characteristics and procedural complications were prospectively 
studied in 110 consecutive patients undergoing percutanaous PFO closure for presumed 
paradoxical embolism. Contrast transesophageal echocardiography was performed 6 
months after device implantation to determine the presence of a residual shunt. The 
results were analyzed according to the type of closure device: PFO-S (n=55) or PFO-A 
(n=55). Predictors for procedural complications and residual shunt were calculated using 
a logistic regression model. 
Results: There were no differences in baseline characteristics (gender, body mass index, 
age, left atrial size, presence of atrial septal aneurysm, degree of shunt before closure) 
between the 2 groups. Device implantation was successful in all patients, however, more 
attempts were required for placing a PFO-S than PFO-A (>1 attempt: 9% vs. 2%, 
p=0.05). The transseptal sheath size was significantly larger in the PFO-S compared with 
the PFO-A group (11.6 +/- 0.15 French vs. 8.5 +/- 0.09 French, p=0.001). There were 
more minor and major adverse events in the PFO-S than PFO-A group (16% vs. 2%, 
p=0.008). The use of a PFO-S device was a significant predictor of procedural Complica- 
tions (odds ratio 10, CI 2.3-81). A significant residual shunt 6 months after intervention 
persisted more frequently in the PFO*S than PFO-A group (27% vs. 2%, p=0.002; odds 
ratio 8.3, CI 1.7-39). Conclusions: Percutaneous PFO closure with the Amplatzer PFO 
Ocoluder appears safer compared with the PFO STAR device. In addition, the Ampiatzer 
PFO Occluder proves more effective with respect to echocardiographic closure 6 months 
after device implantation. Long-term follow-up will be required to determine a difference 
in recurrent hromboembolic events. 
820-4 Percutaneoue Closure of Atrial Septal Defect Under 
Intrecardiac Ultrasound Guidance: Comparison With 
Procedures Guided by Transesophageal 
Echocardiography 
Euloeio Garcts, Enrique Maroto, Raul Moreno, Ignacio Zabala, Oscar Diaz-Castro, 
Carlos Maroto, Jose L. Zunzunegui, Ruben Greco, Hospital Gregorio Maranon, Madrid, 
Spain. 
Percutanenus closure of ostium secundum atrial septal defect (ASD) using the Amplatzer 
closing device is becoming the preferred alternative to surgical repair, Classically, size 
selection, deployment and correct positioning of the device is guided by transesophageal 
echocardiography (TEE). TEE monitoring of percutansous procedures requires complete 
anaesthesia nd orotracheal intubatin in small children and important sedation for adequate 
tolerance in bigger chidren and adult patients. 
Trying to determine the rote of intracardiac ultrasound (ICU) for guidance of percutaneous 
ctosure of ASD using the Amplatzer device, we have analised the results of 90 procedures. 
Out of them, 51 consecutive patients underwent he procedure guided by ICU, and the 
remaining 39 by TEE. ICU guidance was performed with the 9-French 9 MHz ULTRA ICE 
catheter hocked to a Clear View ultrasound console (Boston Scientific, EP Technologies, 
San Jose, CA), which was introduced through the left femoral vein and advanced through 
the right atrium. Procedures guided by the ICU were done in small children under sedation 
without he need of orotracheal intubation and with only local anaesthesia to the groin in big- 
ger chitdrean and adults. 
Results: Demographics and deflect characteristics were similar in both groups. The 
Amplatzer device could not be properly positioned in 3 patients (3.3%) (1 in patients with 
ICU guidance end 2 in those guided by TEE), and was retrieved without complications. Clin- 
ical and echocardiographic follow-up showed favoureble outcome without late in patients of 
both groups. Procedural time (61 vs 85 rain, p--0.01) and radiation exposure (14 vs 22 rain, 
p=0.01) were significantly reduced in the procedures guided by ICU. 
Conclusion: ICU guidance for percutaneous closure using the Ampletser device appears 
like a valuable altemative to TEE monitoring. Procedures performed with ICU are safe, 
equally effective, required less procedural and radiation exposure time, do not required 
orotracheal intubation in small children and were better tolerated by adolescents and adults. 
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1120-97 Video-Assisted Ligation of Patent Ductus Arteriosus: 
Results of Multiple Ligation Technique, Need for 
Transesophageal Echocardiography, and 
Appropriateness of Same-Day Hospital Discharge 
William M. DeCamoli, Kristi L. Peterson, Guillermo R. Sanchez, Richard J. Myung, Mary 
Berry-LeBoeuf, Carolyn Fabian, Gil Wernovsky, The Children's Hospital of Philadelphia, 
Philadelphia, Pennsylvania. 
Background: Surgical management of patent ductus arteriosus (PDA) is usually per- 
formed by thoracotomy using multiple ligation (ML) or by video-assisted thoracoscopic 
surgery (VATS) using a single clip. Most series report a 1-3 day hospital stay. We (1) 
report results of VATS using ML, (2) assess the need for intraoperative transesophageal 
echocardiography (TEE) and (3) assess appropriateness of "same day discharge" from 
the hospital. 
Methods: All pts referred to a single surgeon for VATS ligation of isolated PDA from 3/ 
97-8/01 were included. Through 3-4 5ram incisions, a silk tie and 1 or 2 clips were 
applied to occlude the PDA. TEE was performed in all pts. Discharge occurred when the 
usual criteria for post-operative (post-op) recovery were met and the family consented. 
Follow-up was obtained by phone or mail survey, clinic visit and subsequent echocardio- 
graphy. Hospital charges were obtained from the hospital's databases. 
Results: 91 pts underwent VATS, median age 24 (2-192) months. Mean operative dura- 
tion was 56 + 27 (standard deviation=SD) min. TEE confirmed closure in all cases and 
altered the procedure in 2 cases (additional clip). 46 pts were discharged on the same 
day, 40 the next morning, and 5 two days post-op. Overnight stay was associated with 
afternoon operations or parental influence. There were no rsadmissions. Mean hospital 
charge was $15,140 + $2,889 (SD), including the $2800 TEE fee. Early complications 
included conversion to thoracotomy (2 for exposure, 1 for bleeding) and pneumothorax 
(1). Survey follow-up was obtained in 73/91 patients. Comparing those pts discharged on 
the day of surgery with those dischaged later, there was no significant difference (p=ns) 
between the frequency of pain medication (median=l) or need for parental attendance 
(median=l)on the first night after discharge. 56/73 had no emesis, 59/73 ate normal 
breakfast and 56/66 walked without guarding the morning after discharge. Late complica- 
tions included persistent hoarseness (1), and residual ductal flow (3). 
Conclusion: VATS with ML is an effective method of PDA ligation, with >95% ~ate occlu- 
sion rate. TEE altered the procedure in only 2.2% of cases. "Same day discharge" is safe 
and appropriate following VATS. 
